| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.033 | 0.8 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |